Oxford Vaccine Group begins human trial of Nipah virus vaccine
Oxford Vaccine Group is leading the trail for the Nipah virus vaccine, and the group is backend with the support of CEPI in terms of funds.
Full Article
Oxford Vaccine Group begins human trial of Nipah virus vaccine
DNA
0 shares
1 views
You might like
Related news coverage
Oxford University Kicks off Human Study for AstraZeneca's COVID-19 Vaccine Technology in Nipah Virus Defense
Oxford Vaccine Group, part of the University’s Pandemic Sciences Institute, has commenced the first-in-human trial of the ChAdOx1..
Upworthy
Nipah virus: First vaccine to treat devastating disease with 75% mortality rate goes to trial
The first participants in a trial received doses of a vaccine for the Nipah virus - a disease with a mortality rate of up to 75 per..
Upworthy